Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease

Lancet Neurol. 2024 Sep;23(9):856-857. doi: 10.1016/S1474-4422(24)00272-2.

Authors

Harmen R Moes¹, Erik Buskens², Teus van Laar³

Affiliations

¹ Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands. Electronic address: [email protected].
² Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands.
³ Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, Netherlands.

PMID: 39152017
DOI: 10.1016/S1474-4422(24)00272-2

No abstract available

Publication types

Letter

MeSH terms

Antiparkinson Agents* / administration & dosage
Carbidopa* / administration & dosage
Drug Combinations*
Humans
Infusions, Subcutaneous*
Levodopa* / administration & dosage
Parkinson Disease* / drug therapy

Substances

Levodopa
Carbidopa
Antiparkinson Agents
Drug Combinations
carbidopa, levodopa drug combination